Squarepoint Ops LLC Liquidia Corp Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Liquidia Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 28,886 shares of LQDA stock, worth $647,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,886

Previous 102,260 71.75%

Holding current value

$647,335

Previous $1.51 Million 76.19%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	SELL	$11.99 - $19.3 $879,754 - $1.42 Million	-73,374 Reduced 71.75%	28,886 $359,000
Q2 2025 Aug 14, 2025	SELL	$11.99 - $19.3 $879,754 - $1.42 Million	-73,374 Reduced 71.75%	28,886 $359,000
Q1 2025 Aug 27, 2025	BUY	$11.36 - $16.5 $833,528 - $1.21 Million	73,374 Added 254.01%	102,260 $1.51 Million
Q1 2025 May 15, 2025	BUY	$11.36 - $16.5 $46,246 - $67,171	4,071 Added 4.15%	102,260 $1.51 Million
Q4 2024 Feb 14, 2025	SELL	$9.82 - $11.8 $88,055 - $105,810	-8,967 Reduced 8.37%	98,189 $1.15 Million
Q3 2024 Nov 14, 2024	BUY	$8.9 - $14.11 $221,467 - $351,113	24,884 Added 30.25%	107,156 $1.07 Million
Q2 2024 Aug 14, 2024	BUY	$11.96 - $15.71 $342,510 - $449,902	28,638 Added 53.4%	82,272 $987,000
Q1 2024 May 15, 2024	BUY	$11.35 - $16.73 $369,590 - $544,778	32,563 Added 154.54%	53,634 $791,000
Q4 2023 Feb 14, 2024	SELL	$5.77 - $12.19 $150,827 - $318,646	-26,140 Reduced 55.37%	21,071 $253,000
Q2 2023 Aug 14, 2023	BUY	$6.63 - $9.9 $313,008 - $467,388	47,211 New	47,211 $370,000
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $24,651 - $55,449	-6,609 Reduced 22.38%	22,920 $125,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $99,468 - $222,845	-29,516 Reduced 49.99%	29,529 $129,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $303,491 - $435,752	59,045 New	59,045 $424,000
Q2 2021 Aug 16, 2021	SELL	$2.51 - $3.11 $157,462 - $195,102	-62,734 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.42 - $3.6 $151,816 - $225,842	62,734 New	62,734 $169,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $94,049 - $209,441	-36,173 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.34 - $8.28 $84,213 - $160,665	19,404 Added 115.71%	36,173 $178,000
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $21,413 - $50,404	4,406 Added 35.64%	16,769 $141,000
Q1 2020 May 15, 2020	SELL	$3.31 - $7.15 $113,218 - $244,565	-34,205 Reduced 73.45%	12,363 $58,000
Q4 2019 Feb 14, 2020	BUY	$3.07 - $5.11 $2,084 - $3,469	679 Added 1.48%	46,568 $199,000
Q3 2019 Nov 14, 2019	SELL	$3.29 - $8.24 $62,546 - $156,650	-19,011 Reduced 29.29%	45,889 $163,000
Q2 2019 Aug 14, 2019	BUY	$7.92 - $11.39 $328,188 - $471,978	41,438 Added 176.62%	64,900 $519,000
Q1 2019 May 15, 2019	BUY	$10.82 - $21.79 $253,858 - $511,236	23,462 New	23,462 $267,000

Others Institutions Holding LQDA

# of Institutions

209

Shares Held

47.5M

Call Options Held

1.61M

Put Options Held

1.15M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.44B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Liquidia Corp Transaction History